MORRISTOWN, N.J.--(BUSINESS WIRE)--Durata Therapeutics today announced Kevin C. O’Boyle has been elected as a member of the Company’s Board and will serve as Chair of the Audit Committee. Mr. O’Boyle has over 27 years’ financial and operational experience across several industries.
